Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Oil rises above $115 and Asia stocks slide as Iran war escalates - 2Ageless Tastefulness: An Outline of Valuable Gemstones and Adornments
- 3Turkey's Erdogan denounces Israel-Greece-Cyprus trilateral summit, affirms support for Gaza
- 4A definitive Cruiser Standoff: Decision in favor of Your #1 Ride
- 5Paris Agreement target off the table, report says
- Which camera do you believe is great for first-time clients? !
- BioMarin to acquire Amicus Therapeutics for $4.8 billion in rare disease bet
- Tech for Efficiency: Applications and Apparatuses to Accomplish More
- Hilary Duff announces new album ‘Luck… or Something,’ her first in over 10 years: ‘Excited is the largest understatement’
- Vote In favor of Your #1 Electric Vehicles
- The 15 Most Powerful Forerunners in Business
- Portugal among EU countries with the most people working close to 50 hours a week
- Picking the Right Pot for Your Plants: An Aide for Plant Devotees
- Holiday spots Well known With Americans In 2024
